This brief reports what ServiceNow's 10-K, filed 2026-01-29, states, and nothing else. Every item below is a sentence the filing contains, quoted exactly and verified character-for-character against the document fetched from EDGAR. No inference is drawn and no claim is made about what any figure means.
The figures
| Metric | Value | Period |
|---|---|---|
| RPO | $28.2 billion | December 31, 2025 |
| RPO | 27% | December 31, 2025 |
| CRPO | 25% | December 31, 2025 |
| Sales outside of North America | 37% | December 31, 2025 and 2024 |
| Gains recognized for foreign currency forward contracts from derivatives not designated as hedging instruments | $97 million | year ended December 31, 2025 |
| Remeasurement losses of the related foreign currency denominated assets and liabilities | $113 million | year ended December 31, 2025 |
| Revenues recognized from beginning period deferred revenue | $6.9 billion | year ended December 31, 2025 |
| Revenues recognized from beginning period deferred revenue | $5.7 billion | year ended December 31, 2024 |
| Total non-cancellable RPO under our contracts with customers | $28.2 billion | December 31, 2025 |
| Revenues expected to be recognized from RPO over the following 12 months | 46% | December 31, 2025 |
| Carrying value of our outstanding debt | $1,491 million | December 31, 2025 |
| Carrying value of our outstanding debt | $1,489 million | December 31, 2024 |
| Unamortized debt discount and issuance costs | $9 million | December 31, 2025 |
| Unamortized debt discount and issuance costs | $11 million | December 31, 2024 |
| Estimated fair value of the 2030 Notes | $1,324 million | December 31, 2025 |
| Estimated fair value of the 2030 Notes | $1,247 million | December 31, 2024 |
| Sales and marketing expenses | $534 million | the year ended December 31, 2025 |
| Research and development expenses (R&D) | $417 million | the year ended December 31, 2025 |
| General and administrative expenses (G&A) | $187 million | the year ended December 31, 2025 |
| Stock-based compensation | $209 million | the year ended December 31, 2025 |
Every figure above is quoted from the filing; the sentence it was read from appears under its beat below.
The evidence, by beat
ARR / NRR / NDR growth or dilution
As of December 31, 2025, our RPO was $28.2 billion, of which 46% represented cRPO.
RPO and cRPO increased by 27% and 25%, respectively, compared to December 31, 2024.
RPO and cRPO increased by 27% and 25%, respectively, compared to December 31, 2024.
seat vs consumption / usage-based pricing mix shift
Sales outside of North America represented 37% of our total revenues for each of the years ended December 31, 2025 and 2024.
competitive displacement / win-loss / platform consolidation
The filing names this beat, but no statement in it verified as a verbatim quote, so none is reported here.
AI product monetisation / attach
The acquisition is intended to strengthen the Company’s AI platform by allowing customers to enrich data with meaning, context and relationships while enabling AI agents and workflows to operate.
The acquisition is intended to enhance our Platform with the acquired smart Internet of Things technology, enabling businesses to intelligently action digital and in-store data with enterprise-grade workflows.
guidance raised/cut, outlook change
The gains recognized for foreign currency forward contracts from derivatives not designated as hedging instruments in other expense, net of $97 million, primarily offset the remeasurement losses of the related foreign currency denominated assets and liabilities of $113 million for the year ended December 31, 2025.
The gains recognized for foreign currency forward contracts from derivatives not designated as hedging instruments in other expense, net of $97 million, primarily offset the remeasurement losses of the related foreign currency denominated assets and liabilities of $113 million for the year ended December 31, 2025.
Revenues recognized from beginning period deferred revenue during the years ended December 31, 2025 and 2024 were $6.9 billion and $5.7 billion, respectively.
Revenues recognized from beginning period deferred revenue during the years ended December 31, 2025 and 2024 were $6.9 billion and $5.7 billion, respectively.
As of December 31, 2025, the total non-cancellable RPO under our contracts with customers was $28.2 billion, and we expect to recognize revenues on approximately 46% of these RPO over the following 12 months.
As of December 31, 2025, the total non-cancellable RPO under our contracts with customers was $28.2 billion, and we expect to recognize revenues on approximately 46% of these RPO over the following 12 months.
For the periods ended December 31, 2025 and 2024, the carrying value of our outstanding debt was $1,491 million and $1,489 million, respectively, net of unamortized debt discount and issuance costs of $9 million and $11 million, respectively.
For the periods ended December 31, 2025 and 2024, the carrying value of our outstanding debt was $1,491 million and $1,489 million, respectively, net of unamortized debt discount and issuance costs of $9 million and $11 million, respectively.
For the periods ended December 31, 2025 and 2024, the carrying value of our outstanding debt was $1,491 million and $1,489 million, respectively, net of unamortized debt discount and issuance costs of $9 million and $11 million, respectively.
For the periods ended December 31, 2025 and 2024, the carrying value of our outstanding debt was $1,491 million and $1,489 million, respectively, net of unamortized debt discount and issuance costs of $9 million and $11 million, respectively.
The estimated fair value of the 2030 Notes based on the closing trading price per $100, was $1,324 million and $1,247 million at December 31, 2025 and 2024, respectively.
The estimated fair value of the 2030 Notes based on the closing trading price per $100, was $1,324 million and $1,247 million at December 31, 2025 and 2024, respectively.
cost action / restructuring / headcount
Sales and marketing expenses increased by $534 million for the year ended December 31, 2025, compared to the prior year, primarily due to increased headcount resulting in an increase in personnel-related costs including stock-based compensation and overhead expenses of $332 million, compared to the prior year.
Research and development expenses (“R&D”) increased by $417 million during the year ended December 31, 2025, compared to the prior year, primarily due to increased headcount resulting in an increase in personnel-related costs including stock-based compensation and overhead expenses of $383 million compared to the prior year.
General and administrative expenses (“G&A”) increased by $187 million during the year ended December 31, 2025, compared to the prior year, primarily due to increased headcount resulting in an increase in personnel-related costs including stock-based compensation of $39 million and an increase in outside services of $78 million.
Stock-based compensation increased by $209 million during the year ended December 31, 2025, compared to the prior year, primarily due to additional grants to current and new employees.
Verification ledger
- 41 statements proposed by the extractor
- 22 verified verbatim against the fetched filing (54%)
- 19 discarded — not quotable character-for-character
The verbatim check contains no model: the extractor proposes a statement, and a deterministic substring match against the fetched text decides whether it is admissible. A proposal that does not verify is dropped.
This brief publishes no inference and no synthesis. The publication's inference layer must clear a measured second-lab confirmation threshold before it may appear; it has not, so it is absent by rule rather than by omission.